Quadriceps tendon autograft has emerged as an excellent option for ACL reconstruction, particularly for active patients seeking to return to high-demand sports.This article describes a minimally ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Published results showed autograft and allograft repair ...
Aim To investigate and compare the surgical outcomes of limbal autograft and limbal allograft transplantations in patients with corneal burns. Conclusions Limbal autograft transplantation is an ...
In the MAXA trial, standalone MagnetOs outperformed the gold standard autograft by 73% in posterior spinal fusion in a difficult-to-treat real life patient population (20% smokers). In the STRUCTURE ...
The addition of lateral extra-articular tenodesis to a hamstring autograft in knee surgery in young active patients significantly reduces graft failure and persistent anterolateral rotatory laxity at ...
Anika Therapeutics has decided to withdraw its application for centralized marketing authorization for Hyalograft C autograft, the European Medicines Agency (EMA) announced yesterday. Hyalograft C ...
The Royal Marsden Hospital (RMH) series is the world's largest single-center experience of elective single autografts performed as consolidation therapy in myeloma after a uniform conditioning regimen ...
WAKE FOREST, NC / ACCESSWIRE /March 19, 2021 / Tobra Medical Inc., a specialty medical device company focused on collection of autograft bone, reported the company's sales revenue growth for 2020. The ...
Although there is legitimate research being done on stem cell therapies, a large industry targets patients in developed countries with unproven treatments, using Internet-based marketing. Mass lesion ...
A localized autograft is reusing the bone which was removed from the disc space during the discectomy procedure (CPT 20936), whereas, using bone harvested from another area where a separate incision ...
Kuros announces two prospective and randomized study results from STRUCTURE and MAXA clinical trials
Kuros Biosciences, a leader in next generation bone graft technologies, has announced results from two prospective, randomized clinical studies - the STRUCTURE and MAXA trials. In the MAXA trial, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback